Dengue fever infects nearly 400 million people annually. French drugmaker Sanofi spend $1.8 billion to develop the vaccine. Highly-affected areas in the Phillippines now have access to an immunization program through schools.
Manufacturers are optimistic that the vaccine could reduce infections from dengue in the Phillippines by nearly a quarter over the next five years. About 25,000 people die from dengue fever annually.
More articles on vaccines:
Mumps spread in North Dakota
After getting the boot from Tribeca Film Fest, anti-vaccination film finds new home
Seasonal flu vaccine could reduce risk of stillbirth, study suggests
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
